Answers are grounded in this paper and cite their sources.
During the international conference for health research in Bangkok it was estimated that less than 10% of the total research funds are spent on the diseases that account for 90% of the global burden of disease. This gap which is widely quoted as epitomizing the inequitable nature of health research has profound consequences; these include the following: diseases affecting large proportions of humanity are given comparatively little attention and simple and low-cost technologies are undervalued and hence inadequately researched. It is noted that much of the problem lies in how health research is governed. Based on the state of the global health research it is suggested that too often governance is not good. Imbalances in financial and intellectual resources between the wealthy and poor exist. Evidence indicates that financial and technical support from donors to train and retain national researchers in developing countries and to build up research institutions that provide opportunities for researchers remains inadequate. It is recommended that a change in approach be adopted in which developing countries are seen as partners in producing health research. Such an approach should begin with larger-scale commitments by funding bodies investments in research capacity for the middle to long term and the need to share decision-making.
No takes yet. Share an insight, caveat, or question.
K. Lee (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: